IBM Watson Health pulls plug on Drugs Discovery service
IBM's Watson Health business unit stops offering its Drugs Discovery service due to disappointing sales figures. The AI-based platform is used by pharmaceutical companies to apply artificial intelligence (AI) in the development of new drugs. However, the service remains active for existing customers... Read more